Cryoport, the global provider of temperature-controlled supply chain solutions to the life sciences industry focused on the pharmaceutical and cell and gene therapy markets, today announced a new strategic partnership with Syneos Health, the integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. “Both Cryoport and Syneos Health are world-leading solutions companies with deep expertise and experience supporting clinical and commercial stage therapies. The partnership will support the global advancement of cell and gene therapies, providing the industry’s first fully integrated biopharmaceutical and supply chain solution,” reads the release.
